Consortium Goal
The goal of the CURE Consortium (CKDu CURE) is to identify the causes of CKDu to facilitate the identification of potential therapeutic targets and public health interventions:
- Enable discovery science to understand the causes and disease progression of CKDu.
- Work to finalize ethical epidemiology research designs, execute common strategies for biological sampling and environmental assessment, and apply optimal standardized analytic strategies for samples and data collected from seven field sites in Central America and India.
- Use findings about CKDu etiology to identify potential therapeutic targets and public health interventions for CKDu.
- Disseminate the results to global research and public health communities.
Study Sponsors
Funding provided through grants 1U01DK130060-01, 1U01DK130046-01, 1U01DK130057-01, 1U01DK130044-01, 1U01DK130058-01, 1U24DK130043-01 supported by NIH: National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, and Fogarty International Center.